An international team of doctors led by Joshua Brody, MD, Director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute at Mount Sinai, has made a major breakthrough in treating a ...

A hair extension technician blamed her back pain on her big breasts and battled it with paracetamol for two years - until ...

Caregiving can take many forms, often requiring a profound shift in daily life. While navigating a disease is an immense ...

Waiting for results of a CT scan after a cancer diagnosis is agonizing, as I anxiously await news on whether my disease has ...

Oct. 17, 2024 — Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the immunotherapy nivolumab to a current treatment regimen.

A British woman who blamed her back pain on having E-cup breasts was self-medicating with paracetamol and ibuprofen for ...

While the salesman continued to reach out, the OP finally responded to one of his Teams calls—while sitting in an infusion ...

Lee Greenberger, PhD, has retired as The Leukemia & Lymphoma Society’s chief scientific officer after more than a decade in ...

The widow of an Air Force missileer who died of non-Hodgkin lymphoma has finally secured Department of Veterans Affairs ...

A new type of cell-based immunotherapy shows promise for B-cell lymphomas and - due to innovations in manufacturing - could make future cellular immunotherapies less expensive and more accessible to ...

A new type of cell-based immunotherapy shows promise for B-cell lymphomas, and due to innovations in manufacturing, could ...

A phase 1 clinical trial co-led by researchers at Washington University School of Medicine in St. Louis found that a new type ...